Principal Financial Group
GHDX

Principal Financial Group’s Genomic Health, Inc. GHDX Stock Holding History

Principal Financial Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-199,105
Closed -$13.5M – 2330
2019
Q3 		$13.5M Buy
199,105
+176,932
+798% +$12.2M 0.01% 1041
2019
Q2 		$1.29M Buy
22,173
+770
+4% +$45.6K ﹤0.01% 1803
2019
Q1 		$1.5M Buy
21,403
+809
+4% +$60K ﹤0.01% 1778
2018
Q4 		$1.33M Buy
20,594
+11,255
+121% +$789K ﹤0.01% 1775
2018
Q3 		$655K Buy
9,339
+4,230
+83% +$247K ﹤0.01% 1916
2018
Q2 		$257K Buy
+5,109
New +$203K ﹤0.01% 2109
2014
Q2 		– Sell
-8,085
Closed -$213K – 2341
2014
Q1 		$213K Sell
8,085
-77
-0.9% -$2.21K ﹤0.01% 2110
2013
Q4 		$239K Hold
8,162
– – ﹤0.01% 2089
2013
Q3 		$250K Sell
8,162
-535
-6% -$17.9K ﹤0.01% 2021
2013
Q2 		$276K Buy
+8,697
New +$286K ﹤0.01% 1968

Principal Financial Group's GHDX Position: Q4 2019 in Review

Principal Financial Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 199,105 shares — an estimated $13.5M sold.

Principal Financial Group first reported a position in GHDX in Q2 2013 and held it in 10 quarters. The position peaked at $13.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Principal Financial Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Principal Financial Group sold 199,105 Genomic Health, Inc. shares in Q4 2019, an estimated $13.5M.
  • Principal Financial Group first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 10 quarters.
  • Principal Financial Group's Genomic Health, Inc. position peaked at $13.5M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Principal Financial Group's 13F filing for Q4 2019, filed 5 Feb 2020.